Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
15 hedge funds and large institutions have $2.61M invested in Nemaura Medical, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
6% less funds holding
Funds holding: 16 → 15 (-1)
9% less capital invested
Capital invested by funds: $2.88M → $2.61M (-$271K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.94K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$311 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$61 |
| 4 |
Wells Fargo
San Francisco,
California
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$20.3K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
-$2.32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Alyeska Investment Group
Chicago,
Illinois
| $2.3M | – | – | – |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $121K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $100K | – | – | – |
|
4
State Street
Boston,
Massachusetts
| $49.9K | – | – | – |
|
5
Northern Trust
Chicago,
Illinois
| $24.7K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $6.78K | +$1.94K | +2,695 | +58% |
|
|
7
BlackRock
New York
| $4.3K | -$20.3K | -28,131 | -86% |
|
|
8
Wells Fargo
San Francisco,
California
| $3.84K | +$3 | +4 | +0.1% |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.8K | – | – | – |
|
|
NA
10
NewEdge Advisors
New Orleans,
Louisiana
| $333 | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $158 | +$61 | +85 | +100% |
|
12
Morgan Stanley
New York
| $93 | – | – | – |
|
13
JP Morgan Chase
New York
| $11 | – | – | – |
|
|
TM
14
Tiger Management
New York
| – | -$336K | -375,000 | Closed |
|
|
15
Simplex Trading
Chicago,
Illinois
| – | -$2.32K | -3,219 | Closed |
|
|
16
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$311 | +432 | New |
|
NMRD Hedge Fund Activity: Q2 2023 in Review
15 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q2 2023, worth a combined $2.61M — down 9.4% from $2.88M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NMRD and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $1.94K. The largest seller was BlackRock, cutting an estimated $20.3K.
- 15 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q2 2023, down from 16 in Q1 2023.
- Funds reported $2.61M of Nemaura Medical, Inc. Common Stock stock for Q2 2023, down 9.4% quarter-over-quarter.
- 1 fund opened new Nemaura Medical, Inc. Common Stock positions in Q2 2023 and 2 closed out, a net change of -1 holder.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q2 2023 was Tower Research Capital (TRC), an estimated $1.94K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q2 2023 was BlackRock, an estimated $20.3K sold.
Based on aggregated 13F filings for Q2 2023.